IIQ Insider Trading

Insider Ownership Percentage: 22.68%
Insider Buying (Last 12 Months): A$32,309.08
Insider Selling (Last 12 Months): A$0.00

INOVIQ Insider Trading History Chart

This chart shows the insider buying and selling history at INOVIQ by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

INOVIQ Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/6/2022 01:04 PM ET

This chart shows the closing price history over time for IIQ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

INOVIQ Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2023Philip (Phil) PowellInsiderBuy20,000A$0.57A$11,400.00
3/3/2023Philip (Phil) PowellInsiderBuy19,481A$0.56A$10,909.36
3/1/2023Philip (Phil) PowellInsiderBuy18,518A$0.54A$9,999.72
5/13/2022Philip (Phil) PowellInsiderBuy20,000A$0.53A$10,620.00
5/6/2022Geoffrey CummingInsiderBuy32,967A$0.61A$20,076.90
5/2/2022Philip (Phil) PowellInsiderBuy50,000A$0.58A$29,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for INOVIQ (ASX:IIQ)

14.22% of INOVIQ stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.
Read More on INOVIQ

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of INOVIQ?

INOVIQ's top insider investors include:
  1. Geoffrey Cumming (Insider)
  2. Philip (Phil) Powell (Insider)
Learn More about top insider investors at INOVIQ.